The Intercontinental Journal of Internal Medicine aims to publish issues related to all fields of internal medicine of the highest scientific and clinical value at an international level and accepts articles on these topics. This journal is indexed by indices that are considered international scientific journal indices (DRJI, ESJI, OAJI, etc.). According to the current Associate Professorship criteria, it is within the scope of International Article 1-d. Each article published in this journal corresponds to 5 points.

EndNote Style
Original Article
Isolated first hour hyperglycemia in oral glucose tolerance test is associated with insulin resistance
Aims: To investigate metabolic and hemogram derived inflammatory markers in patients with isolated hyperglycemia on 1st hour of oral glucose tolerance test.
Methods: The subjects undergone 75 g OGTT for any reason were enrolled to the present retrospective cross sectional study. Plasma glucose, insulin and hemogram derived inflammatory markers, including mean platelet volume (MPV), neutrophil to lymphocyte ratio (NLR), and platelet to lymphocyte ratio (PLR) of the subjects in isolated hyperglycemia group compared to those in healthy controls.
Results: Mean PLR of the isolated hyperglycemia and control groups were 106.4±28.8% and 121.4±38%, respectively (p=0.043). Mean HOMA–IR values of patients and controls were 4.09±2.84 and 3.02±2.2, respectively (p=0.027). Plasma glucose at 1st hour was significantly correlated with fasting insulin (r=0.286; p=0.018) and HOMA-IR (r=0.32; p=0.007).
Conclusion: We think that isolated 1st hour hyperglycemia in OGTT should not be classified as normal since it is associated with increased fasting insulin and HOMA-IR levels. However, studies with larger cohort are needed to confirm our results

1. Association AD. 5. Prevention or delay of type 2 diabetes: standards ofmedical care in diabetes-2018. Diabetes care. 2018;41(Supplement_1):S51-S54.
2. Jagannathan R, Sevick MA, Li H, et al. Elevated 1-hour plasma glucoselevels are associated with dysglycemia, impaired beta-cell function, andinsulin sensitivity: a pilot study from a real world health care setting.Endocrine. 2016;52(1):172-175.
3. Priya MM, Amutha A, Pramodkumar T, et al. β-Cell function andinsulin sensitivity in normal glucose-tolerant subjects stratified by1-hour plasma glucose values. Diabetes Technology & Therapeutics.2016;18(1):29-33.
4. Tabák AG, Herder C, Rathmann W, Brunner EJ, Kivimäki M.Prediabetes: a high-risk state for diabetes development. Lancet.2012;379(9833):2279-2290.
5. Buysschaert M, Bergman M, Valensi P. 1-h post-load plasma glucose fordetecting early stages of prediabetes. Diabetes Metab. 2022;48(6):101395.
6. Bergman M, Manco M, Sesti G, et al. Petition to replace currentOGTT criteria for diagnosing prediabetes with the 1-hour post-loadplasma glucose≥ 155 mg/dl (8.6 mmol/L). Diabetes Res Clinic Pract.2018;146:18-33.
7. Succurro E, Marini MA, Arturi F, et al. Elevated one-hour post-loadplasma glucose levels identifies subjects with normal glucose tolerancebut early carotid atherosclerosis. Atherosclerosis. 2009;207(1):245-249.doi:10.1016/j.atherosclerosis.2009.04.006
8. Wu X, Chen H, Wang Y, Li H. The relationship between coronary riskfactors and elevated 1-h postload plasma glucose levels in patients withestablished coronary heart disease. Clin Endocrinol (Oxf). 2013;78(1):67-72.
9. Paddock E, Looker HC, Piaggi P, Knowler WC, Krakoff J, Chang DC.One-hour plasma glucose compared with two-hour plasma glucose inrelation to diabetic retinopathy in American Indians. Diabetes Care.2018;41(6):1212-1217.
10. Badimon L, Vilahur G. Thrombosis formation on atherosclerotic lesionsand plaque rupture. J Int Med. 2014;276(6):618-632.
11. Chu S, Becker R, Berger P, et al. Mean platelet volume as a predictor ofcardiovascular risk: a systematic review and meta-analysis. J ThrombosisHaemostasis. 2009;8(1):148-156.
12. Korniluk A, Koper-Lenkiewicz OM, Kaminska J, Kemona H, Dymicka-Piekarska V. Mean platelet volume (MPV): new perspectives for anold marker in the course and prognosis of inflammatory conditions.Mediators Inflam. 2019;2019:1-14.
13. Shimodaira M, Niwa T, Nakajima K, Kobayashi M, Hanyu N, NakayamaT. Correlation between mean platelet volume and fasting plasma glucoselevels in prediabetic and normoglycemic individuals. CardiovascDiabetol. 2013;12:1-7.
14. Coban E, Kucuktag S, Basyigit S. Platelet activation in subjects withimpaired glucose tolerance. Platelets. 2007;18(8):591-594.
15. Nording HM, Seizer P, Langer HF. Platelets in inflammation andatherogenesis. Front Immunol. 2015;6:98.
16. Mertoglu C, Gunay M. Neutrophil-Lymphocyte ratio and Platelet-Lymphocyte ratio as useful predictive markers of prediabetes anddiabetes mellitus. Diabetes Metab Syndr. 2017;11(Suppl 1):S127-S131.
17. Stern MP, Rosenthal M, Haffner SM, Hazuda HP, Franco LJ. Sexdifference in the effects of sociocultural status on diabetes andcardiovascular risk factors in Mexican Americans: the San AntonioHeart Study. Am J Epidemiol. 1984;120(6):834-851.
18. Bardini G, Dicembrini I, Cresci B, Rotella CM. Inflammation markersand metabolic characteristics of subjects with 1-h plasma glucose levels.Diabetes Care. 2010;33(2):411-413.
19. Succurro E, Arturi F, Lugara M, et al. One-hour postload plasma glucoselevels are associated with kidney dysfunction. Clin J Am Soc Nephrol.2010;5(11):1922-1927.
20. Succurro E, Arturi F, Grembiale A, et al. One-hour post-load plasmaglucose levels are associated with elevated liver enzymes. NMCD.2011;21(9):713-718. doi:10.1016/j.numecd.2011.02.002
21. Abdul-Ghani MA, Williams K, DeFronzo RA, Stern M. What is the bestpredictor of future type 2 diabetes? Diabetes Care. 2007;30(6):1544-1548.
22. Abdul-Ghani MA, Abdul-Ghani T, Müller G, et al. Role of glycatedhemoglobin in the prediction of future risk of T2DM. J Clin EndocrinolMetab. 2011;96(8):2596-2600.
23. Galimzhanov A, Tenekecioglu E, Rustamova F, Tun HN, Mamas MA.The prognostic utility of mean platelet volume in patients with acutecoronary syndrome: a systematic review with meta-analyses. Angiology.2022;73(8):734-743.
24. Xue W, Li Y, Xia H, Yu T, Sun S, Zhang M. Influence of neutrophil-to-lymphocyte ratio and mean platelet volume on severity and short-termprognosis of acute ischemic stroke. Am J Transl Res. 2022;14(6):4066.
25. Li F, Ye P, Hao Y, et al. A PCSK9 inhibitor induces a transient decrease in theneutrophil-lymphocyte ratio and monocyte-lymphocyte ratio in homozygousfamilial hypercholesterolemia patients. Atheroscler Plus. 2022;49:12-19.
26. Oğlak SC, Tunç Ş, Ölmez F. First trimester mean platelet volume,neutrophil to lymphocyte ratio, and platelet to lymphocyte ratio values areuseful markers for predicting preeclampsia. Ochsner J. 2021;21(4):364-370.
27. Inaoka K, Kanda M, Uda H, et al. Clinical utility of the platelet-lymphocyte ratio as a predictor of postoperative complicationsafter radical gastrectomy for clinical T2-4 gastric cancer. World JGastroenterol. 2017;23(14):2519.
28. Coban E, Ozdogan M, Yazicioglu G, Akcit F. The mean platelet volume inpatients with obesity. Int J Clin Pract. 2005;59(8):981-982.
29. Park HS, Park JY, Yu R. Relationship of obesity and visceral adipositywith serum concentrations of CRP, TNF-α and IL-6. Diabetes Res ClinPract. 2005;69(1):29-35.
30. Grossmann V, Schmitt VH, Zeller T, et al. Profile of the immune andinflammatory response in individuals with prediabetes and type 2diabetes. Diabetes Care. 2015;38(7):1356-1364.
31. Maschirow L, Khalaf K, Al-Aubaidy H, Jelinek H. Inflammation,coagulation, endothelial dysfunction and oxidative stress in prediabetes-Biomarkers as a possible tool for early disease detection for ruralscreening. Clinic Biochemistry. 2015;48(9):581-585.
32. Wang Z, Shen X-H, Feng W-M, Ye G-f, Qiu W, Li B. Analysis ofinflammatory mediators in prediabetes and newly diagnosed type 2diabetes patients. J Diabetes Res. 2016:2016:7965317.
33. Johnson JL, Duick DS, Chui MA, Aldasouqi SA. Identifying prediabetesusing fasting insulin levels. Endocrine Pract. 2010;16(1):47-52.
34. Tabák AG, Jokela M, Akbaraly TN, Brunner EJ, Kivimäki M, Witte DR.Trajectories of glycaemia, insulin sensitivity, and insulin secretion beforediagnosis of type 2 diabetes: an analysis from the Whitehall II study.Lancet. 2009;373(9682):2215-2221.
35. Vozarova B, Weyer C, Lindsay RS, Pratley RE, Bogardus C, TataranniPA. High white blood cell count is associated with a worsening of insulinsensitivity and predicts the development of type 2 diabetes. Diabetes.2002;51(2):455-461.
36. Mauer J, Chaurasia B, Goldau J, et al. Signaling by IL-6 promotesalternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin. Nat Immunol. 2014;15(5):423-430.
37. Rehman K, Akash MSH, Liaqat A, Kamal S, Qadir MI, Rasul A. Role ofinterleukin-6 in development of insulin resistance and type 2 diabetesmellitus. Critical Reviews™ in Eukaryotic Gene Expression. 2017;27(3):229-236.
Volume 2, Issue 1, 2024
Page : 1-6